baber/WOPTO huggingface dataset:
Patent NZ-594260-A (NZ)
Title: Portable chargeable spraying bottle
Inventor: HUI YI MING
IPC: B05B11/02
Filed: 2009-06-19
Abstract: 594260 Disclosed is a portable chargeable spray bottle having an inner bottle and a nozzle assembly on the upper part of the inner bottle. The bottle has a liquid charging structure provided at the lower part of the bottle, with the liquid charging structure having a stepped liquid charging mouth (21); a protuberant grooved piston (5) provided in the liquid charging mouth; and a resetting structure of the piston, wherein a liquid charging passage (51) is arranged on the piston and is fitted with a discharging opening (510). The bottle further has an exhaust structure including an exhaust hole (26) provided in the lower part of the bottle, and an air duct interconnected with the exhaust hole (26) and extending to the upper part of inner bottle. The bottle has a stop block (52) with one flared end provided at the top of the piston, and a first sealing ring, (53) capable of performing static sealing, arranged on the stop block, wherein a dynamic sealing is formed by the exhaust hole (26) and a second sealing ring (54) in the groove of the piston.:
Patent NZ-595617-A (NZ)
Title: Improvements relating to covering
Inventor: WEST KATHRINE
IPC: A47D15/02
Filed: 2010-03-31
Abstract: 595617 Disclosed is a device for covering a baby resting on an upper surface of an item, such as a mattress or car seat. The device comprises a sleeve, having an open end to receive, or fit over, a portion of the item. The sleeve has a lower sheet, which acts as an encasement about a lower surface of the item, and a foldable upper sheet releasably engaged with the lower sheet, and which partially covers the upper surface of the item. The device further includes an adjustable strap attached to opposite sides of the lower sheet to enable the sleeve to secure about the item, such that only a portion of the item is received within the sleeve. The upper sheet is releasably engaged to the remainder of the sleeve such that the upper sheet is able to fold away in its entirety from the sleeve and uncover the baby. The upper sheet comprises two layers, and includes a closable opening extending through one of the two layers for receiving a supplementary blanket (9) therebetween. This advantageously prevents multiple layers of bedding becoming tangled, thereby reducing the risk of a baby’s face becoming covered.
Patent NZ-598524-A (NZ)
Title: Therapeutic dll4 binding proteins
Inventor: BENATUIL LORENZO
IPC: C07K16/28
Filed: 2010-08-27
Abstract: Disclosed is a binding protein comprising an antigen binding domain, said binding protein being capable of binding human DLL4, said antigen binding domain comprising six CDRs as defined in the complete specification. Also disclosed in the use of the binding protein in the manufacture of a pharmaceutical composition for reducing human DLL4 activity.
Patent NZ-598798-A (NZ)
Title: Recombinator for flowing electrolyte battery
Inventor: WINTER ALEXANDER RUDOLF
IPC: H01M50/77
Filed: 2010-10-22
Abstract: 598798 Disclosed herein is a recombinator for a flowing electrolyte battery comprises a housing defining a reaction chamber for receiving a halogen source and a hydrogen source. A catalyst is located within the reaction chamber to catalyse the formation of hydrogen halide from the halogen source and the hydrogen source and substantially all of the halogen source, hydrogen source and hydrogen halide within the reaction chamber are maintained in gaseous form.
Patent NZ-599373-A (NZ)
Title: Biomarkers for predicting rapid response to hcv treatment
Inventor: CHIU SHU-HUI
IPC: C12Q1/70
Filed: 2010-11-11
Abstract: Patent No. 599373 Disclosed is a method for predicting that a human subject infected with Hepatitis C Virus Genotype 1(HCV-l) or Hepatitis C Virus Genotype 4 (HCV-4) will achieve Rapid Virologic Response-2 Weeks (RVR2) to treatment with pegylated interferon alpha, ribavirin and a HCV NSSB polymerase inhibitor selected from the group consisting of (i) Isobutyric acid (2R,3S,4R,SR)-S-(4-amino-2-oxo-2H-pyrimidin-1-yl)-2-azido-3,4-bis-isobutyryloxy-tetrahydro-furan-2-ylmethyl ester (R04S88161), (ii) Isobutyric acid (2R,3R,4R,SR)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-4-fluoro-3-isobutyryloxy-4-methyl-tetrahydro-furan-2-ylmethyl ester (RO5024048), and (iii) pharmaceutically acceptable acid addition salts of (i) and (ii), the method comprising: (i) determining the expression level in a sample isolated from said subject prior to said treatment of at least one protein selected from the group consisting of MDC, Eotaxin, ILlO, TARC, and MCP1, and (ii) comparing the expression level of the at least one protein in said sample to a reference value representative of an expression level of the at least one protein derived from pre-treatment samples of a patient population that did not achieve RVR2 to said treatment; wherein a statistically significant higher expression level ofthe at least one protein in said sample is indicative that said subject will achieve RVR2 to said treatment.
Patent NZ-601341-A (NZ)
Title: Acaricide and/or insecticide active substance combinations
Inventor: FISCHER REINER
IPC: A01N63/16
Filed: 2011-01-14
Abstract: Disclosed herein is an active ingredient combination comprising a dihydrofuranone compound of formula (I) (spiromesifen) with abamectin at a ratio of 10:1 or 20:1. Said combinations are useful in controlling animal pests more particularly for controlling animal pests from the families of Aleyrodidae, Thripidae, Psyllidae and Agromyzidae, and also, more particularly, from the order of the Acari.
Patent NZ-603967-A (NZ)
Title: 8-hydroxy-quinoline derivatives
Inventor: PUSKAS LASZLO
IPC: A61K31/47
Filed: 2011-05-06
Abstract: The disclosure relates to compounds of the general formula (I), their pharmaceutically acceptable salts and a process for the preparation of these compounds, wherein the variables are as defined in the specification. These compounds can be used in the medicine mainly for the treatment of diseases associated with neurological and/or oxidative stress, which are selected from the following: ischemia, reperfusion injury, cardiovascular disorders, neurodegenerative disorders (including especially Alzheimer’s disease and Huntington’s disease), trauma, neuropsychiatric diseases (including especially depression and anxiety disorders), and liver, kidney and lung injuries.
Patent NZ-606490-A (NZ)
Title: Immunogenic anti-inflammatory compositions
Inventor: GUNN HAROLD DAVID
IPC: G01N33/48
Filed: 2011-07-26
Abstract: Disclosed is a use of an anti-inflammatory composition in the manufacture of a medicament for treating an individual for an inflammatory bowel disease (IBD) characterised by inflammation in a region of the gastrointestinal tract (GIT), wherein the anti-inflammatory composition comprises antigenic determinants selected or formulated so that together they are specific for at least one microbial pathogen that is pathogenic in the region of the GIT, and wherein the medicament is formulated for use by a route that is not enteric, and wherein the pathogens are as disclosed in the specification. Also disclosed is a method for formulating such a composition.
Patent NZ-612175-A (NZ)
Title: Anti ccr4 antibodies and uses thereof
Inventor: HAGEMANN URS BEAT
IPC: G01N33/574
Filed: 2011-12-07
Abstract: Disclosed is an antibody which binds to human CC chemokine receptor 4 (CCR4) and which is capable of inhibiting the binding of macrophage-derived chemokine (MDC) and/or thymus and activation regulated chemokine (TARC) to CCR4, and which comprises at least one heavy chain variable region that comprises three CDRs and at least one light chain variable region that comprises three CDRs, wherein the CDRs are as disclosed in the complete specification. Also disclosed is the use of said antibody in the manufacture of a medicament for the treatment or diagnosis of a condition associated with increased CCR4 expression or activity.
Patent NZ-700988-A (NZ)
Title: Electronic vapour provision device
Inventor: LORD CHRISTOPHER
IPC: A24F40/53
Filed: 2013-05-14
Abstract: An electronic vapour provision device comprising a battery assembly and a vaporiser, wherein the battery assembly comprises a power cell and a computer. The vaporiser is releasably connectable to the battery assembly and the computer comprises a computer processor and a memory; wherein the computer is configured to detect whether the vaporiser is connected to the battery assembly without use of the electronic vapour provision device by a user; and to substantially remain in a sleep mode until the vaporiser is connected to the battery assembly. The computer is configured to wake from sleep mode after a predetermined sleep time to determine whether the vaporiser is connected to the battery assembly; and to re−enter sleep mode if a vaporiser is not connected to the battery assembly. This enables the computer to determine whether the vaporiser is connected and configure the device as required.
Patent NZ-702974-A (NZ)
Title: Novel indanesulfamide derivative
Inventor: TANAKA TOSHIAKI
IPC: C07C307/08
Filed: 2013-06-17
Abstract: A novel indanesulfamide compound, such as N-[(1S)-2,2,5,7-tetrafluoro-2,3-dihydro-1H-inden-1-yl]- sulfamide, N-[(1S)-2,2,4,7-tetrafluoro-2,3-dihydro-1H- inden-1-yl]sulfamide and (+)-N-(2,2,4,6,7- pentafluoro-2,3-dihydro-1H-inden-1-yl)sulfamide, or a pharmaceutically acceptable salt thereof has an effect of improving the severity (score) of an attack in a mouse kindling model and therefore can be expected to serve as a therapeutic agent for epilepsy.
Patent NZ-706334-A (NZ)
Title: Oil formulations with thickeners
Inventor: JACOBSON RICHARD MARTIN
IPC: A01N25/04
Filed: 2013-09-11
Abstract: The treatment of plants or plant parts with cyclopropoenes is often used to interrupt one or more ethylene-mediated process in the plants or plant parts and thereby desirably delay unwanted ripening. The cyclopropene is often used in the form of a complex with a molecular encapsulating agent, which is dissolved or suspend as solid particles in a liquid. It is often desirable to suspend such particles in oil as water causes release of the cyclopropene from the complex earlier than desired. Oil suspensions of particles often displayed problems such as the suspensions could not be sprayed properly, the suspensions have too high viscosity at reasonable concentration of particles, the suspensions were not stable, the suspension settled or creamed, or the suspensions had some combination of these problems. This invention is based on unexpected effect of at least one thickener to maintain suspension or dispersion of solid particles in an oil medium. Such effect of thickener enables significant higher weight ratio of solid particles in such suspension composition as compared to previously known compositions. As a consequence, the suspension compositions provided herein enable more active ingredient in the solid particle to be present in a fixed volume or weight of such composition as compared to previously known compositions.
Patent NZ-709048-A (NZ)
Title: Wall mountable storage assembly with articulating connection
Inventor: THOMPSON CRAIG D
IPC: F16B5/07
Filed: 2013-12-06
Abstract: A wall mountable storage assembly including a storage device, at least one mounting plate, and at least one double-faced adhesive with enhanced ability to conform to contoured surfaces. The storage device includes a coupling bracket forming a first engagement feature. The mounting plate forms a second engagement feature. The first and second engagement features have a complimentary construction configured to provide a releasable snap fit connection in which the mounting plate can articulate relative to the coupling bracket, a relationship which can ensure proper contact of the double-faced adhesives with a contoured surface to which the storage device is being secured. The adhesive is configured to be arranged between the mounting plate and a wall, with the mounting plate articulating relative to the coupling bracket to facilitate complete contact between the adhesive and the wall. The storage device can include two spaced-apart coupling brackets. Two of the mounting plates are provided, each carrying adhesive. The mounting plates can articulate independent of one another, accommodating variations in flatness of the wall to which the storage assembly is mounted.
Patent NZ-712834-A (NZ)
Title: Exercise aid
Inventor: ATTALAH OMAR
IPC: A63B23/02
Filed: 2014-02-21
Abstract: An exercise device is disclosed which is more effective and efficient than the traditional sit up, but does not include the inherent negative side effects. The exercise device, comprises a pair of arcuate tube housings; a plurality of compression mechanisms positioned at ends of said pair of tube housings; a plurality of height adjustment mechanisms releasably connected to said compression mechanisms; a width-adjustment mechanism releasably connected to said pair of tube housings; wherein said pair of tube housings are adapted to be placed between the chest and legs while said compression mechanisms provide resistance during use, wherein the tube housings are arranged at a distance from each other and the width adjustment mechanism is configured to adjust the distance between the tube housings. These components work in conjunction to form an abdominal exercise machine that is more safe and efficient than traditional abdominal exercises thus providing an exercise device which is intuitive to use, will have increased efficiency, and can be used in a variety of ways.
Patent NZ-713701-A (NZ)
Title: Method for pre-stressing a steel structure, and a steel structure pre-stressed thereby
Inventor: MOTAVALLI MASOUD
IPC: E01D22/00
Filed: 2014-04-16
Abstract: According to the method, at least one carbon fiber-reinforced polymer band is joined to the steel structure at the end regions thereof, capable of transferring tensile forces. Subsequently, at least one lifting element (7) disposed between the carbon fiber-reinforced polymer band (4) and the steel girder (3) to be reinforced in a region between these end anchorages (5), is extended substantially perpendicular to the carbon fiber-reinforced polymer band (4). So, a tensile force stress is generated between the end regions of the carbon fiber-reinforced polymer band (4). Then, a steel girder treated in such a manner includes at least one carbon fiber-reinforced polymer band, which is each joined to the steel structure (1) at the end regions thereof, capable of transferring tensile forces. In the region between these end regions, a lifting element (7) is disposed between the carbon fiber-reinforced polymer band (4) and the steel girder (3) to be reinforced, by means of which the carbon fiber-reinforced polymer band (4) is subjected to tensile stress by lifting away from the steel girder (3). The tensile force is transferred to the steel girder (3) via the anchoring elements (5).
Patent NZ-713750-A (NZ)
Title: Method for preparing a liquid oat base and products prepared by the method
Inventor: RASCON ANA
IPC: A23L33/21
Filed: 2014-03-03
Abstract: The invention relates to a method of preparing a liquid oat base having improved smoothness, wherein a material comprising oat bran is suspended in an aqueous media and contacted with α-amylase, β-amylase, β-glucanase, and xylanase to raise the concentration of soluble arabinoxylan by a factor of 5 or more. Also disclosed is a liquid oat base obtainable by the method; a powderous oat base obtained by drying the liquid oat base; uses of the liquid and powderous oat bases and food products comprising them. A powderous composition for use in preparing a liquid oat base comprises oat bran, α-amylase, β-amylase, β-glucanase, and xylanase.
Patent NZ-727770-A (NZ)
Title: An electromechanical hoist for eliminating the possibility of loss of control of a load following a single point failure in a drive train and a method of operation thereof
Inventor: CLEGG CHRISTOPHER JAMES
IPC: G05B9/03
Filed: 2015-05-22
Abstract: The present invention relates to a hoist comprising a pair of drive trains connected to a lifting mechanism. The drive trains are both connected to a detection arrangement configured to detect asynchronous movement between the drive trains, and to operate a failsafe brake in the event of detection of asynchronous movement. Invention further comprises a detection arrangement for use in such a hoist.
Patent NZ-729395-A (NZ)
Title: Therapeutic agent for cancer which comprises combination of il-18 and molecule-targeting antibody
Inventor: OKAMURA HARUKI
IPC: A61P43/00
Filed: 2015-08-07
Abstract: A cancer therapeutic agent according to an embodiment of the present invention contains, as active ingredients, IL-18 and one or more antibodies selected from the group consisting of an anti-PD-L1 antibody, an anti-PD-1 antibody, an anti-PD-L2 antibody, an anti-CTLA-4 antibody, an anti-CD25 antibody, an anti-CD33 antibody, and an anti-CD52 antibody.
Patent NZ-730091-A (NZ)
Title: Exercise apparatus simulating mild to high altitude environments
Inventor: WILLIAMS ROBERT
IPC: E04B1/16
Filed: 2015-08-10
Abstract: A personal physical conditioning system for a single full-size human subject is disclosed. The personal physical conditioning system allows simultaneous simulation of mild to high altitude environments with controlled variations in pressure that may be pre-programmed or personally developed via physiological feedback during training. The personal physical conditioning system comprises: a sealable chamber configured to allow entry therein and occupancy thereof by an entirety of the human subject and to allow the human subject to exercise in a standing position using an item of physical conditioning equipment entirely contained within the sealable chamber; a ventilation system, including a pump, operable to change air in the sealable chamber and to establish, within the sealable chamber, a desired non-zero air pressure level of less than 1 atmosphere and down to pressure conditions substantially equivalent to an elevation of 25,000 feet above sea level; a monitoring system operable to monitor vital signs of the human subject, the vital signs including at least one parameter selected from the group consisting of heart rate, breathing rate, skin temperature, oxygen saturation, and combinations thereof; and a controller coupled to the ventilation system and operable to regulate air pressure in the sealable chamber at the desired non-zero air pressure level under specifiable conditions; wherein the sealable chamber has a size and shape for use in an interior space and wherein the monitoring system is configured to monitor the vital signs of the human subject while the entirety of the human subject is in the sealable chamber.
Patent NZ-730862-A (NZ)
Title: Neuroactive compounds and methods of use thereof
Inventor: MARTINEZ BOTELLA GABRIEL
IPC: A61K31/56
Filed: 2015-10-07
Abstract: Methods for treating a subject suffering from a sterol synthesis disorder or a sterol deficiency disorder, e.g., Smith-Lemli-Opitz syndrome, the method comprising administering to the subject an effective amount of an NMDA receptor modulating compound, are provided.
Patent NZ-733102-A (NZ)
Title: Medical corset
Inventor: TRIBE ANTHONY EDWARD
IPC: A61F5/03
Filed: 2015-12-18
Abstract: A medical corset intended to limit chest expansion of a wearer. The corset consists of two side panels (103, 104) joinable at the front by a slide fastener and at the back by at least two adjustable fasteners (111). The two adjustable fasteners include indicia (114) or markings that allows the length to which they have been set to be visibly determinable. This allows easy determination of whether the corset has become maladjusted. The adjustment is intended to limit the chest expansion of the wearer and the slide fastener allows removing or donning the corset without changing the adjustment.
Patent NZ-738353-A (NZ)
Title: Transport charter system and a method thereof
Inventor: WADHWA SACHIT
IPC: G06Q50/30
Filed: 2016-05-14
Abstract: A system for pricing and reserving charter vehicle services includes a central database, first and second real-time databases, and a controller. The central database receives and stores itinerary data. The controller searches the first real-time database to identify at least one route between the departure and destination locations and the second real-time database to determine whether a charter vehicle is capable of being operated on the routes. The controller further determines availability of the charter vehicle and the routes and determines feasibility of operating the charter vehicle on the routes, generates travel schedules, provides prices for travel schedules, receives payment for one of the travel schedules, and reserves the travel schedule.
Patent PT-103732-A (PT)
Title: Produtos naturais bioactivos de plantas do género calystergia/convolvulus específicos contra a tuberculose (mycobacterium tuberculosis e outras micobacterias não tuberculosas)
Inventor: LUNA-HERRERA JULIETA
IPC: A61K36/39
Filed: 2007-05-07
Abstract: A PRESENTE INVENÇÃO RELACIONA-SE COM A ACTIVIDADE ANTITUBERCULOSE DE EXTRACTOS E FRACÇÕES E, COM O ISOLAMENTO E ACTIVIDADE ANTI-MYCOBACTERIUM DE RESINAS GLICOSÍDICAS (GLICORESINAS MACROCÍCLICAS OU LACTONAS MACROCÍCLICAS GLICOLÍPIDICAS) PROVENIENTES DE ESPÉCIES DE PLANTAS EUROPEIAS DO GÉNERO CALYSTEGIA (ANTERIORMENTE DESIGNADO CONVOLVULUS) DA FAMÍLIA DAS CONVOLVULÁCEAS. A PRESENTE INVENÇÃO DESCREVE TAMBÉM A ACTIVIDADE BIOLÓGICA E O MÉTODO DE EXTRACÇÃO E PURIFICAÇÃO DE UMA RESINA DO TIPO TETRASSACARIDEO NÃO-LINEAR ACILADA, DENOMINADA SOLDANELLINE B: ÁCIDO (11S)-HIDROXIHEXADECANOICO 11-O-{3-O-[ (2S)-METILBUTANOILO] - BETA-D-GLUCOPIRANOSILO}- (1->3)-O-{ 2-O-[(2S, 3R) -3-HIDROXI-2-METILBUTANOILO] }-4-O- [ (Z) -2-METIL-2-BUTENOILO] -ALFA-L-RAMNOSILO-(1->2) ] O-BETA-D-GLUCOPIRANOSILO-(1->2) ]-BETA-D-QUINOVOPIRANOSIDO, INTRAMOLECULAR 1,2''-ESTER E O ISOLAMENTO DE COMPOSTOS QUIMICAMENTE ANÁLOGOS. A INVENÇÃO APRESENTA A UTILIZAÇÃO DOS EXTRACTOS E DOS SEUS COMPOSTOS QUÍMICOS CONSTITUINTES NO TRATAMENTO E/OU PREVENÇÃO DA TUBERCULOSE RESISTENTE E INFECÇÕES PROVOCADAS POR MICOBACTERÍAS NÃO TUBERCULOSAS.
Patent PT-103865-A (PT)
Title: Nano-transportadores de base lipídica para entrega direccionada de vectores virais e processo para a sua produção
Inventor: GIACCA MAURO
IPC: C12N15/861
Filed: 2007-10-25
Abstract: A PRESENTE INVENÇÃO ESTÁ RELACIONADA COM NANOPARTÍCULAS TRANSPORTADORAS DE MATERIAL GENÉTICO, PARTICULARMENTE NA FORMA DE VÍRUS RECOMBINANTES (VECTORES VIRAIS), COMPOSTAS POR VESÍCULAS LIPÍDICAS, CONTENDO LÍPIDOS NEUTROS E/OU NEUTROS E NEGATIVOS, UM VECTOR VIRAL E UM LIGANDO RESPONSÁVEL PELO DIRECCIONAMENTO DAS NANOPARTÍCULAS PARA AS CÉLULAS ALVO QUE O VECTOR VIRAL IRÁ TRANSDUZIR, POR FORMA A GARANTIR UMA ENTREGA ESPECÍFICA DE GENES A CÉLULAS ALVO, BEM COMO O SEU PROCESSO DE OBTENÇÃO. O PROCESSO DE OBTENÇÃO DAS NANOPARTÍCULAS INCLUI BASICAMENTE TRÊS ETAPAS: 1) ASSOCIAÇÃO DOS VECTORES VIRAIS ÀS VESÍCULAS LIPÍDICAS; 2) CONJUGAÇÃO DE UM POLÍMERO HIDROFÍLICO À SUPERFÍCIES DAS NANOVESÍCULAS; 3) CONJUGAÇÃO DE UM LIGANDO À EXTREMIDADE DISTAL DO POLÍMERO HIDROFÍLICO. DESTA FORMA A INVENÇÃO APRESENTA CARACTERÍSTICAS ADEQUADAS PARA ENTREGA DE GENES A UM CONJUNTO ESPECÍFICO DE CÉLULAS APÓS ADMINISTRAÇÃO, NOMEADAMENTE INTRAVENOSA, INDEPENDENTEMENTE DO TROPISMO NORMAL DO VECTOR ASSOCIADO AOS LIPOSSOMAS, PERMITINDO O TRATAMENTO DE PATOLOGIAS EM QUE AS CÉLULAS ALVO DA TERAPIA NÃO ESTEJAM DIRECTAMENTE ACESSÍVEIS A UMA APLICAÇÃO LOCAL E MINIMIZANDO OS EFEITOS SECUNDÁRIOS CONSEQUENTES DA INTERACÇÃO NÃO ESPECÍFICA DOS VECTORES VIRAIS COM OUTRAS CÉLULAS, ASSIM COMO A RESPOSTA IMUNITÁRIA INATA DESENCADEADA CONTRA ESTES VECTORES, APLICANDO-SE, POR ISSO, NA ÁREA FARMACÊUTICA.